-
-
As we reported previously, scientists from the University of New Mexico have been studying how access to marijuana may help alleviate the opioid crisis, declared a national emergency by President Trump. Their study has now been published in the journal PLOS One, with the researchers concluding that there is “clinically and statistically significant evidence” that increased cannabis use led to patients cutting down on opioids and improved their quality of life.
The study analyzed the health data of 66 patients who were using opioids habitually to manage their severe chronic pain. 37 of the patients were enrolled in a medical marijuana program between 2010 and 2015 while 29 patients in the control group were not.
The scientists found that patients using cannabis were 17 times more likely to stop their prescribed opioids and five times more likely to lower their daily dosage of opioids. On average, they cut their doses in half. Comparatively, the patients not enrolled in the medical marijuana program actually increased their opioid usage by more than 10%.
http://bigthink.com/paul-ratner/how-legalizing-marijuana-may-end-the-opioid-crisis
-
-
The clinically and statistically significant evidence of an association between MCP enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.
Study: http://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0187795
-
MPs passed the Liberal government’s bill to legalize cannabis Monday evening, sending the legislation down the hall to the Senate for further study and debate.
The legislation was largely supported along partisan lines, although it secured the support of the NDP and Green Party Leader Elizabeth May. The final vote was 200 MPs in favour, with 82 against. Conservative MP Scott Reid voted for the bill after he polled constituents in his eastern Ontario riding, Lanark—Frontenac—Kingston, and found a plurality supported the Liberal plan.
A last-ditch Conservative effort to delay the bill — and send it to the Commons health committee for further study — failed by a vote of 83 to 199 with some Bloc Québecois MPs voting with Tory legislators. Conservative opposition will now fall to their national caucus colleagues in the Red Chamber, where some senators have already signalled they are prepared to give the bill a rough ride. Some Tories have said the government’s timeline for legalization, July 1, 2018, is far too ambitious.
Continues: http://www.cbc.ca/news/politics/cannabis-legalization-legislation-1.4421910
-
Press conference for the new report by the Global Commission on Drug Policy calling for an end to all criminal and civil penalties for drug consumption and possession for personal use. The Global Commission on Drug Policy comprises 23 high-level members, including nine former Heads of State and government and a former Secretary General of the United Nations.
-
‘Taking a New Line on Drugs’ assesses the situation in the UK as regards rising health harm from illegal drugs, with reference to their context within the wider ‘drugscape’ of legal drugs such as alcohol and tobacco, and sets out a new vision for a holistic public health-led approach to drugs policy at a UK-wide level
From a public health perspective, the purpose of a good drugs strategy should be to improve and protect the public’s health and wellbeing by preventing and reducing the harm linked to substance use, whilst also balancing any potential medicinal benefits. RSPH is calling for the UK to consider exploring, trialling and testing such an approach, rather than one reliant on the criminal justice system.
Read more: Taking a New Line on Drugs
-
-
“Drugs have destroyed many people, but wrong policies have destroyed many more”, said Kofi Annan, the former UN Secretary-General. Indeed, international drug policy has been fraught with inconsistency and controversy. Global drug control started when the first international drug treaty—The International Opium Convention—was signed at The Hague, Netherlands, in 1912. However, a global system against narcotic drugs was not fully fledged until 1961, when the Single Convention on Narcotic Drugs was adopted. The Convention is an international treaty that seeks to prohibit production and allow supply of narcotic drugs exclusively for medical and scientific purposes, and combats drug trafficking through international cooperation. Although considered as a landmark convention in the history of the campaign against narcotic drugs and the bedrock of the current UN-based global drug control regime, the Single Convention on Narcotic Drugs was also criticised as neither reflecting the huge negative impact of pursuing drug prohibition on public health and human rights nor being scientifically grounded. For the first time in two decades, the UN General Assembly’s Special Session (UNGASS; April 19–21, 2016) will be about the world drug problem. It will be a crucial moment for revisiting and reforming international drug policy.
